Life Tech Relies on Partners, Acquisitions to Develop Personalized Rx Decision Support Tool for Docs | GenomeWeb

Life Technologies is tapping the expertise of several personalized medicine companies — some through partnerships and others through acquisitions — to develop a decision-support tool and knowledge portal that doctors can use to deliver individualized treatment strategies for cancer patients.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.